SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Speculating in Takeover Targets
ULBI 6.950-1.1%Nov 3 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Labrador who wrote (5104)12/26/2018 2:42:48 PM
From: richardred  Read Replies (1) of 7239
 
Your right about that, insider selling, and you could be right of no hypothetical offers. However IMO the selling,that's a sign the board wouldn't oppose a reasonable takeover offer. The board Selling at these price shows no long term confidence in the company, only executive compensation. The Restaurant group has been a favorite in acquisitions among private equity. I see the trend continuing. I believe BLMN is a value for a private equity firm. Outback Steakhouse's Brand Name recognition is high and gas prices are down.

P.S.RE- Speculating In Development pharma companies. I at one time speculated in this. Ariad and Spectrum Pharma. RE- IMMU looks to have potential. I'll add it to the watch list. Well rounded CEO promising pipeline. Correct me If I'm wrong.. I believe the FDA approval process takes time, even drugs on fast track ? I believe Orphan drugs have a better chance because of a limited market? I always cringed when it was time for the final FDA approval.

Message 26886766
Message 30924240

Message 27732459
Message 27009483

Message 26999646
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext